ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 23297 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 23297; 2) Community: the network communities that were significantly associated with the response to NSC 23297; 3) Molecule: the relationships between components within communities and NSC 23297; 4) MDR: the compounds that were significantly associated with the NSC 23297.

NSC Compound Enrichment Correlation
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.03551961774939 0.31860132
NSC 751500 Null 0.03551961774939 -0.0048866787
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.03551961774939 0.29443927
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.03551961774939 0.036672512
NSC 83066 8-Quinolinol, 5-(chloromethyl)-, hydrochloride 0.03551961774939 0.37284371
NSC 87500 Solacongestidine 0.03551961774939 0.28318479
NSC 94945 Questiomycin A 0.03551961774939 0.11605976
NSC 234214 NSC 234214 0.0361455178924428 0.46419309
NSC 271674 Carboxyphthalatoplatinum 0.0361455178924428 0.40843817
NSC 400245 2,7-Dimethyl-1,4-naphthoquinone 0.0361455178924428 0.33581479
Total:96  Current:76    [First] [Prev] [Next] [Last]